Achieving Diversity and Inclusion in Oncology Clinical Trials

This panel, first recorded at the 2022 IO360° Summit, reported on advances in achieving more diversity and inclusion in oncology clinical trials.

Moderated by:
Adrelia Allen, PharmD, Director, Clinical Trial Patient Diversity, Global Clinical Trial Operations, Merck Research Labs

Panelists:

• Chétna Rao, PhD, Head of Site Strategy and Operations, BMS
• Robert Vonderheide, MD, DPhil, Director, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
• Karen Peterson, Patient Advocate and Founder, Karen’s Club
• Michel Reid, Sr. Director and Head, Global Demographics & Diversity, Global Clinical, Delivery, Global Clinical Operations, R&D, GSK

Learn more about the IO360° Summit at www.io360summit.com